Department of Health (DOH) (MANILA BULLETIN)
“Of all of these things that we have done, I am sure and I am confident to tell all of you that we were able to improve our health system capacity,” said DOH Undersecretary Maria Rosario Vergeire.
Vergeire said that the country now has a total of 212 licensed-laboratories for COVID-19 testing, while the temporary treatment and monitoring facilities nationwide currently stood at 11,000, adding that all health protocols “are in place.”
“I guess that being said sa tingin ko naman yung response natin ay naging appropriate although hindi po namin sinasabi na naging perpekto, marami po tayong mga naging gaps dito sa mga ginagawa natin but tuloy tuloy pa rin tayo to further improve the system [I guess that being said, I think our response has been appropriate although we are not saying that it’s perfect. We also have gaps in our efforts but we will continue to further improve the system],” she said.
Two Catholic bishops say they are willing to receive a coronavirus vaccine publicly to urge their followers to get vaccinated against a disease that has already killed over 10,000 in the Philippines.
Pasig City is the first local government unit (LGU) to have a vaccination plan approved by the Department of Health (DOH) and World Health Organization (WHO).
President Duterte has offered his presidency to prove that Vaccine Czar Carlito Galvez, Jr. is not corrupt following questions on the government's acquisition of COVID-19 vaccines.
Galvez explains why PH may get higher rates for Sinovac vaccine
enablePagination: false
endIndex: Vaccine Czar Carlito Galvez, Jr. said the reason other countries may get COVID-19 vaccines from China s Sinovac at a cheaper price is because of cost-reducing conditions such as agreeing to produce the vaccine shots themselves using materials from the company. (FILE PHOTO)
Metro Manila (CNN Philippines, January 22) Vaccine Czar Carlito Galvez, Jr. said the reason other countries may get COVID-19 vaccines from China s Sinovac at a cheaper price is because of cost-reducing conditions such as agreeing to produce the vaccine shots themselves using materials from the company.